Evidence map›Paper›PMID 40689359›Full record

ArticleFrontiers in research metrics and analytics2025

Assessing biomedical research capacities in selected countries of Latin America: challenges, opportunities, and recommendations.

Jorge A Huete-Perez, Narayana Salvatierra

Abstract read
In one paragraph

Article in Frontiers in research metrics and analytics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jorge A Huete-PerezScience, Technology and International Affairs, Georgetown University, Washington, DC, United States.
Narayana SalvatierraCenter for Community, Service and Justice, Loyola University Maryland, Baltimore, MD, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite increasing scientific output, biomedical research in Latin America remains unevenly developed, particularly in countries that are often overlooked in regional science policy discussions. This study assesses research capacities in Colombia, Costa Rica, Guatemala, Panama, and Peru, identifying key challenges, opportunities, and strategies to strengthen the region's scientific landscape. Using a mixed-methods approach-including surveys, expert interviews, and data analysis-this study examines infrastructure, institutional support, funding mechanisms, researcher training, and international partnerships. Additionally, it evaluates the impact of global programs, such as the Pew Latin American Fellows Program, in advancing research capacity. Findings highlight substantial differences in national R&D investment, workforce development, and institutional capabilities. Colombia and Costa Rica exhibit more developed research ecosystems, while Guatemala, Panama, and Peru face constraints such as limited national funding, dependency on external grants, and gaps in PhD/postdoctoral training. However, emerging opportunities include specialization in key biomedical fields, notably infectious diseases, genomics, and biotechnology, strengthening global partnerships, and leveraging research networks to address Latin America's pressing health challenges. This study contributes to ongoing discussions on regional science policy and international collaboration by addressing knowledge gaps and providing evidence-based recommendations for research funding, institutional development, and workforce expansion. To foster long-term growth, it recommends increasing national R&D investment, modernizing research infrastructure, expanding doctoral and postdoctoral training, and strengthening institutional and global research partnerships. By implementing targeted policies and institutional strategies, Latin America can enhance its role in global biomedical research and innovation while addressing regional health priorities.

Indexed as

biomedical researchglobal partnershipsLatin AmericaR&D investmentresearch capacityscience policy

Identifiers

PMID40689359
PMCPMC12271115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.